栄研化学(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4549/E00961 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/11/22 | 日証協 | 656,143株 | +1.88% | 127,932株 | -81.43% | 709,174株 | -0.25% | 61,400株 | -43.32% |
2018/11/16 | 日証協 | 644,017株 | +11.75% | 688,764株 | +1.5% | 710,949株 | +7.43% | 108,331株 | +111.58% |
2018/11/09 | 日証協 | 576,280株 | +12.28% | 678,555株 | -17.08% | 661,749株 | +16.1% | 51,200株 | -86.28% |
2018/11/02 | 日証協 | 513,270株 | +163.96% | 818,307株 | +144.87% | 569,985株 | +175.99% | 373,203株 | +89.57% |
2018/10/26 | 日証協 | 194,451株 | -45.55% | 334,177株 | -27.96% | 206,523株 | -39.19% | 196,866株 | +143.39% |
2018/10/19 | 日証協 | 357,122株 | +8.39% | 463,884株 | +35.81% | 339,608株 | +4.64% | 80,884株 | -23.13% |
2018/10/12 | 日証協 | 329,483株 | -2.6% | 341,573株 | -30.38% | 324,551株 | -0.61% | 105,228株 | +106.69% |
2018/10/05 | 日証協 | 338,277株 | +13% | 490,632株 | +9.25% | 326,551株 | -2.93% | 50,910株 | +68.75% |
2018/09/28 | 日証協 | 299,370株 | +15.52% | 449,093株 | +16.15% | 336,407株 | -2.56% | 30,168株 | -60.97% |
2018/09/21 | 日証協 | 259,148株 | +5.61% | 386,636株 | +59.84% | 345,251株 | +12.87% | 77,300株 | +119.6% |
2018/09/14 | 日証協 | 245,387株 | -0.41% | 241,887株 | +58.64% | 305,889株 | +2% | 35,200株 | -37.7% |
2018/09/07 | 日証協 | 246,387株 | +5.8% | 152,472株 | +59.34% | 299,889株 | +9.69% | 56,500株 | -32.98% |
2018/08/31 | 日証協 | 232,887株 | +1.83% | 95,687株 | -40.31% | 273,389株 | +23.45% | 84,302株 | +100.4% |
2018/08/24 | 日証協 | 228,700株 | +4.96% | 160,300株 | +38.79% | 221,459株 | +13.67% | 42,066株 | -9.75% |
2018/08/17 | 日証協 | 217,897株 | +6.55% | 115,497株 | +24.46% | 194,821株 | +4.87% | 46,613株 | +49.24% |
2018/08/10 | 日証協 | 204,500株 | -29.28% | 92,800株 | -32.48% | 185,777株 | -33.28% | 31,233株 | -18.9% |
2018/08/03 | 日証協 | 289,167株 | -31.28% | 137,441株 | -72.23% | 278,444株 | -32.27% | 38,510株 | -34.39% |
2018/07/27 | 日証協 | 420,767株 | +5.58% | 494,993株 | +29.5% | 411,134株 | +0.44% | 58,693株 | -48.13% |
2018/07/20 | 日証協 | 398,547株 | 0% | 382,225株 | 0% | 409,335株 | 0% | 113,151株 | 0% |
※株式分割は考慮していませんのでご注意ください。
Page Top